Published research exists for ingredients in this formula — see Related research below. Whether this product’s doses match those studies could not be confirmed.

Kirkland Omega-3 Fish Oil 1,000 mg 300 Softgels
Marketing check: 1 remains partly or independently unverified.
Rebuilt from public sources on July 23, 2026 · evidence availability is not a safety or effectiveness verdict.
Does the marketing hold up?
Couldn’t verify means public proof was not found; it is not a mark against the product. Ingredient research is not treated as a trial of this exact product.
◐Partly confirmed1
Marketing language, not scored
High Omega-3 Premium Fish Oil
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
The headline amount is not tied to a same-name panel row
You are being sold on an ingredient the verified panel does not separately declare. The brand should explain the mismatch.
Evidence and sources
The listing presents 1,000 mg for fish oil, but vision:google/gemini-flash-1.5 does not contain a same-name quantified row. The retained image read may be incomplete, so this is a specific question to resolve rather than a contradiction.
Locked evidence record →Open the full source-linked findingEvery declared ingredient has an amount · 2 quantified rows.
You can compare each declared dose with research instead of guessing what is hidden inside a blend.
Evidence and sources
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingWhat remains open 2
- No FDA recall matched this brand in the current search.
- No dated review-history series is on file yet.
These are evidence gaps, not strikes against the product.
Dose and research context
Ingredient context used alongside the captured panel. These sources do not test this product or establish safety or effectiveness.
0.75 g declared
The panel declares 750 mg EPA + DHA per serving, within one studied 300–1800 mg/day context. The fish-oil concentrate total is not substituted for EPA + DHA.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Open the full evidence trailSources, edge cases, and every unresolved check
Confirmed evidence
What checked out02
These checks found support in the public record. They confirm specific facts, not the product as a whole.
EPA + DHA dose is within one studied range
The panel declares 750 mg EPA + DHA per serving (1 softgel). One randomized dose-response trial used 300–1,800 mg/day; omega-3 studies vary widely. This is research context, not a recommendation or safety verdict.
Every ingredient amount is disclosed
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Documented concerns
What needs caution00
These are documented contradictions or claims that need more evidence. They are separate from missing data.
No contradictions or product-specific cautions were found at this check depth.
Unresolved public record
What is still missing05
We looked for these signals but could not settle them from public sources. A gap is not a strike.
The listing doesn't publish enough to check the math
The retained listing evidence does not establish net weight, unit count, per-serving dose, servings per container, so the dose claim cannot yet be checked against serving arithmetic. This is a neutral evidence gap, not a pass or strike.
Review-count history: not available
Marketplace rating not shown★ — rating count unavailable. No exact-listing count history was available, so no review-pattern claim is made.
The headline amount is not tied to a same-name panel row
The listing presents 1,000 mg for fish oil, but vision:google/gemini-flash-1.5 does not contain a same-name quantified row. The retained image read may be incomplete, so this is a specific question to resolve rather than a contradiction.
Research context is available for the listed ingredients
Published sources describe how omega-3 have been studied. This is ingredient context only; the record does not establish that this product delivers the studied dose or outcome. Sources: NIH ODS — Omega-3 Fatty Acids fact sheet, PubMed dose-response trial.
No recall found — which is not the same as being tested
This means only that no enforcement record matched the brand name — it does not mean the product was tested, reviewed, or cleared by FDA. New and untested products also have no recall records.
What to ask and check
What would settle the open questions
Why is this shown?
Ask the brand or seller
What is the product’s UPC or GTIN?
The barcode is how a product gets matched to outside records — certification registries, label databases, recall data. Without it, almost nothing can be cross-checked.
Is this label filed with NIH’s Dietary Supplement Label Database (DSLD)?
Filing is voluntary, so absence proves nothing — but a filed label puts the full ingredient table on public record where anyone can read it.
Most brands and sellers publish a contact route. A clear answer adds evidence to the record; no answer leaves the question open.
Check for yourself — no one’s permission needed
Compare the panel on the bottle in your hand to the one shown in this record.
Ours was read from listing photos and can contain reading errors. The physical label is the source of truth — if they disagree, tell us and we’ll correct the record.
Check the lot number and expiry on the bottle against any COA you’re given.
A certificate that doesn’t name your lot doesn’t describe what you’re holding.
These are the open questions on this specific record — not a warning about the product, and not a suggestion to buy or avoid it. Getting them answered is how you decide for yourself.
Record built July 23, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.